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Abstract: 
Apoptosis is a process of controlled cellular death whereby the activation of specific death-
signaling  pathways  leads  to  deletion  of  cells  from  tissue.  Apoptosis  is  considered  a  vital 
component  of  various  processes  including  normal  cell  turnover,  proper  development  and 
functioning of the immune system, hormone-dependent atrophy, embryonic development and 
chemical-induced cell death. 
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Introduction:- 
In  addition  to  cell-cycle  arrest  and 
repair machinery, the damaged cells, where 
damage  is  beyond  repair,  may  induce  an 
apoptotic  (programmed  cell  death  -  PCD) 
response  that  is  highly  cell-specific  and  is 
the most common form of physiologic cell 
death in multicellular forms.
4 Apoptosis is a 
process of controlled cellular death whereby 
the  activation  of  specific  death-signaling 
pathways  leads  to  deletion  of  cells  from 
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be activated in response to receptor–ligand 
interactions, environmental factors  such as 
ultraviolet  light  and  redox  potential,  and 
internal  factors  that  are  encoded  in  the 
genome (“programmed cell death”).
1 
HISTORICAL OVERVIEW:- 
Apoptosis  has  long  been  identified 
as  an  evolutionarily  conserved  process  of 
active cell elimination during development. 
Its  phenotypic  features  include  DNA 
fragmentation and chromatin condensation, 
cell  shrinkage,  and  formation  of  apoptotic 
bodies,  which  are  cleared  by  phagocytosis 
without  initiating  a  systemic  inflammatory 
response.  The  execution  of  apoptosis 
requires novel gene expression and protein 
synthesis.  Apoptosis  has  evolved  as  an 
intricate  and  critical  mechanism  for 
balancing cell proliferation and for the active 
remodelling of tissues during development. 
The  identification  of  apoptosis 
under pathological settings dates back to the 
1960s,  when  John  FR  Kerr  was  studying 
ischemic liver damage. He observed a novel 
cell  death  phenotype  that  was 
morphologically  distinct  from  classical 
necrosis. Dying hepatocytes in the ischemic 
penumbra  were  found  to  have  shrunk  to 
form  small  round  masses  of  cytoplasm 
containing  condensed  nuclear  chromatin. 
These  dying  cells  were  taken  up  by 
neighbouring  hepatocytes  and  phagocytes 
without  initiating  a  broader  inflammatory 
response.  This  phenomenon  was  also 
recognized in normal rat livers. This distinct 
type  of  cell  death,  temporarily  named 
'shrinkage necrosis', was also found to occur 
in cancer and during normal development. 
The  term  'apoptosis'  was  subsequently 
coined  to  replace  shrinkage  necrosis,  and 
has  later  been  used  interchangeably  with 
programmed  cell  death,  albeit  loosely, 
because of similar requirements for genetic 
programming and new protein synthesis, as 
well as morphological similarities.
7 
Cell death, along with differentiation 
and growth, is a fundamental aspect of the 
life cycle of a eukaryotic cell, the control of 
cell  number  is  the  result  of  the  balance 
between  cell  loss  and gain.  The  molecular 
mechanisms  leading  to  the  controlled 
removal of cells in tissues by apoptosis are 
not fully understood. It is clear that under 
physiological  conditions  the  process  is 
active,  requires  energy  and  the 
induction/activation of specific genes have 
led  to  the  identification  of  several  genes 
needed for the completion of the cell death 
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into  specific  functional  groups  that  play 
distinct roles within the cell death program. 
The first group of genes includes permissive 
elements  which  specify  which  cells  will 
undergo  apoptosis.  The  second  group 
comprises  elements  whose  induction  or 
down-regulation  initiates  the  apoptosis 
pathway.  A  third  set  of  genes  includes 
effector elements required for killing and the 
subsequent  disposal  and  degradation  of 
cellular  remnants.  Genes  with  functional 
homology to some of those defined in C. 
elegans  have  been  described  in  mammals: 
Bcl-2 and ted-9, caspases and ted-3. These 
genes,  grown into  families of homologous 
genes,  together  with  additional  important 
regulatory  elements,  are  at  the  centre  of 
intense  research  efforts  to  dissect  the 
molecular  mechanisms  of  the  death 
machinery.
5 
Some  cells  express  Fas  or  TNF 
receptors  that  can  lead  to  apoptosis  via 
ligand  binding  and  protein  cross-linking. 
Other  cells  have  a  default  death  pathway 
that  must  be  blocked by  a  survival  factor 
such as a hormone or growth factor. There 
is also the issue of distinguishing apoptosis 
from necrosis, two processes that can occur 
independently, sequentially, as well as 
simultaneously. In some cases it’s the type 
of  stimuli  or  the  degree  of  stimuli  that 
determines  if  cells  die  by  apoptosis  or 
necrosis. At low doses, a variety of injurious 
stimuli such as heat, radiation, hypoxia and 
cytotoxic  anticancer  drugs  can  induce 
apoptosis but these same stimuli can result 
in  necrosis  at  higher  doses.  Finally, 
apoptosis is a coordinated and often energy-
dependent  process  that  involves  the 
activation of a group of cysteine proteases 
called “caspases” and a complex cascade of 
events that link the initiating stimuli to the 
final demise of the cell.
6 
MECHANISMS OF APOPTOSIS: 
Mainly  two  types  of  apoptotic 
pathways such as intrinsic and extrinsic (or 
death  receptor)  have  been  well  described 
that involve a number of proteins.  
Extrinsic apoptosis pathways of type I and 
type II-  
   Extrinsic  apoptosis  signalling  is 
mediated  by  the  activation  of  so  called 
“death  receptors”  which  are  cell  surface 
receptors  that  transmit  apoptotic  signals 
after  ligation  with  specific  ligands.  Death 
receptors  belong  to  the  tumor  necrosis 
factor  receptor  (TNFR)  gene  superfamily, 
including  TNFR-1,  Fas/CD95,  and  the 
TRAIL  receptors  DR-4  and  DR-5.  All 
members  of  the  TNFR  family  consist  of 
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allow them to recognize their ligands with 
specificity, resulting in the trimerization and 
activation of the respective death receptor. 
Subsequent  signalling  is  mediated  by  the 
cytoplasmic  part  of  the  death  receptor 
which  contains  a  conserved  sequence 
termed  the  death  domain  (DD).  Adapter 
molecules  like  FADD  or  TRADD 
themselves possess their own DDs by which 
they  are  recruited  to  the  DDs  of  the 
activated  death  receptor,  thereby  forming 
the  so-called  death  inducing  signalling 
complex (DISC). In addition to its DD, the 
adaptor  FADD  also  contains  a  death 
effector  domain  (DED)  which  through 
homotypic  DED-DED  interaction 
sequesters  procaspase-8  to  the  DISC.  As 
described above, the local concentration of 
several procaspase-8 molecules at the DISC 
leads  to  their  autocatalytic  activation  and 
release of active caspase-8. Active caspase-8 
then  processes  downstream  effector 
caspases which subsequently cleave specific 
substrates  resulting  in  cell  death.  Cells 
harboring the capacity to induce such direct 
and  mainly  caspase-dependent  apoptosis 
pathways were classified to belong to the so 
called type I cells.  
In  type  II  cells,  the  signal  coming 
from  the  activated  receptor  does  not 
generate a caspase signalling cascade strong 
enough  for  execution of  cell death on  its 
own.  In  this  case,  the  signal  needs  to  be 
amplified  via  mitochondria-dependent 
apoptotic  pathways.  The  link  between  the 
caspase  signalling  cascade  and  the 
mitochondria  is  provided  by  the  Bcl-2 
family  member  Bid.  Bid  is  cleaved  by 
caspase-8 and in its truncated form (tBID) 
translocates  to  the  mitochondria  where  it 
acts in concert with the proapoptotic Bcl-2 
family members Bax and Bak to induce the 
release  of  cytochrome  c  and  other 
mitochondrial proapoptotic factors into the 
cytosol. Cytosolic cytochrome c is binding 
to  monomeric  Apaf-1  which  then,  in  a 
dATP-dependent  conformational  change, 
oligomerizes to assemble the apoptosome, a 
complex of wheel-like structure with 7-fold 
symmetry, that triggers the activation of the 
initiator  procaspase-9.  Activated  caspase-9 
subsequently  initiates  a  caspase  cascade 
involving  downstream  effector  caspases 
such as caspase-3, caspase-7, and caspase-6, 
ultimately resulting in cell death.
2,3 
Intrinsic pathway of apoptosis:- 
Following DNA damage, there is an 
increase  in  level  of  Bax  and  decrease  in  
level of Bcl-2, which causes mitochondria to 
release  pro-apoptotic  factors,  such  as 
cytochrome-c.  These  factors  cause 
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downstream apoptotic effectors. Recently, it 
has  been  found  that in response to  DNA 
damage, activation of caspase-2 is required 
before  mitochondrial  permeabilization  and 
release  of  cytochrome-c.    Expression  of 
cyclin-D3  and  caspase-2  in  human  cells 
potentially induces apoptosis. After releasing 
cytochrome-c, it binds to apoptotic protease 
activating factor Apaf-1 and forms a 7-span 
symmetrical active complex ‘apoptosome’ in 
nucleotide dATP/ATP dependent manner. 
The  apoptosome  subsequently  recruits 
procaspase-9 into its central region to form 
an  active  holoenzyme,  which  further 
activates downstream executioner caspases, 
such  as  caspase-3/7  that  leads  to  PCD 
(programmed  cell  death).  In  mammalian 
cells,  caspase  activity is  also stimulated  by 
one  of  the  pro-apoptotic  mitochondrial 
proteins  Smac/Diablo,  and  Omi/HtrA2, 
They interfere with the action of inhibitor of 
apoptosis(IAP) family protein (e.g., survivin) 
and  promote  apoptosis.  In  addition  to 
caspase  activator  proteins,  some  other 
molecules such as AIF (apoptosis inducing 
factor) and Endo G (endonuclease G) has 
also  been  found  to  be  released  from 
mitochondria that cause apoptosis by DNA 
fragmentation and subsequent chromosomal 
condensation. Recent evidence suggests that 
Bax/Bak  can  also  be  localized  in  the 
endoplasmic  reticulum  (ER)  and  gets 
activated in response to ER stress, leading to 
calcium  depletion  and  murine  caspase-12 
activation. 
In addition to other organisms, PCD 
has  also  been  suggested  in  various 
phytoplankton species such as cyanobacteria 
(e.g.,  Trichodesmium  sp.,  Anabaena  flos-
aquae),  green  algae  (e.g.,  Dunaliella 
tertiolecta)  and  dinoflagellates  (e.g., 
Peridinium  gatunense).  However,  it  is  not 
very  clear  how  PCD  is  operating  in 
phytoplankton.  The  presence  of  key 
apoptotic enzymes such as paracaspase (in 
bacteria), metacaspase  (in  plant/fungi) and 
caspases  (in  animals)  that  share  common 
active  sites  are  considered  to  be  highly 
conserved  across  taxa,  although,  the 
presence of animal cell death regulator, such 
as Bcl-2 family and p53 in all the life forms 
is still in dispute.
2,3,4 
MALFUNCTIONING  OF 
APOPTOSIS:- 
Improper  apoptosis  or 
malfunctioning  of  individual  apoptotic 
machinery  may  cause  several  human 
diseases  like  cancer,  neurodegenerative  as 
well  as  several  types  of  autoimmune 
disorder. It has been found that unnecessary 
cell death and unsound regulation of caspase 
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such  as  Alzheimer’s  disease,  Parkinson’s 
disease  and  Huntington’s  disease. 
Augmented  activities  of  caspases-8  and  -9 
have  been  observed  in  peripheral  blood 
mononuclear  cells  of  Alzheimer’s  disease 
patients  and in brain tissues of Alzheimer’s 
as  well  as  Parkinson’s  disease  patients. 
Huntington’s  disease,  a  neurodegenerative 
disorder, has also been found to be caused 
by  increased  activity  of  caspase-10  in  a 
manner similar to caspase-8. Mutations on 
Fas and Fas ligand (Fas-L) in humans may 
cause  a  complicated  immune  disorder  like 
autoimmune  lymphoproliferative  syndrome 
(ALPS),  a  semblance  of  murine 
lymphoproliferation  (lpr)  and  generalized 
lymphoproliferative disorder (gld).  
The  three  autosomal  dominant 
diseases  such  as  Muckle  Wells  syndrome, 
familial  cold  auto-inflammatory  syndrome 
and chronic infantile neurological cutaneous 
and articular (CINCA) syndrome caused by 
missense mutations in the NACHT domain 
of  NALP3  protein  are  closely  related  to 
autoinflammatory  syndromes  distinguished 
by  periodic  fever,  skin  rashes,  amyloidosis 
and  development  of  neurological 
complications.  It  has  been  suggested  that 
loss of caspase-14  expression is  associated 
with progression of ovarian cancer  and the 
mutation in p53 gene may cause neoplastic 
diseases.  Thus  it  seems  that  apoptotic 
pathway is associated with several biological 
processes and plays a vital role in regulating 
various diseases.
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Conclusion: 
Apoptosis  is  a  energy-dependent 
flow of  molecular events  and triggered  by  
certain  stimuli  such  as  UV  radiation, 
oxidative stress, genotoxic chemical with in 
biological  system.  It  course  through  two 
types  of  pathways  such  as  intrinsic  and 
extrinsic that involves the activation of a set 
of cysteine proteases known as “caspases”. 
Apoptosis plays a significant role in survival 
by  maintaining  the  homeostasis  in 
multicellular  organisms  as  well  as  in  the 
management  of  many  diseases. 
Malfunctioning  of  apoptotic  pathway  may 
cause  several  human  diseases  like  cancer, 
neurodegenerative as well as several types of 
autoimmune  disorder.  Certain 
photosensitizing drugs  are being employed 
in  photodynamic  therepy  to  induce 
apoptosis for the treatment of  cancer and 
non cancer cells.  
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